SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-010747
Filing Date
2020-04-15
Accepted
2020-04-15 14:08:56
Documents
2
Period of Report
2020-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1611
2 EX-24 DOCUMENT attachment1.htm EX-24 4099
  Complete submission text file 0000899243-20-010747.txt   7067
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Fishman Corey N. (Reporting) CIK: 0001553594 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19879 | Film No.: 20793324